drugset / Trial / NCT00599664

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

NCT00599664 ↗

Phase 1 Completed 11 enrolled Omeros Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluate the safety and systemic absorption of OMS201 following exposure during ureteroscopy.

Timeline

Start
2007-12
Primary completion
—
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject OMS201 Unknown — —

Indications